R E L A P S E D / R E F R A C T O R Y
|
|
- Jeffery O’Brien’
- 8 years ago
- Views:
Transcription
1 This activity is provided by prime Oncology. Satellite Symposium at the 20th Congress of the European Hematology Association R E L A P S E D / R E F R A C T O R Y M U L T I P L E M Y E L O M A : EMBRACING THE PERSON IN PERSONALIZED CARE Thursday, 11 June Room C1 Reed Messe Vienna Messeplatz Vienna, Austria This educational activity is supported by grants from Bristol-Myers Squibb; Celgene; Novartis Oncology; and Onyx Pharmaceuticals, an Amgen subsidiary.
2 Satellite Symposium at the 20 th Congress of the European Hematology Association RELAPSED/REFRACTORY EMBRACING THE PERSON IN PERSONALIZED CARE MULTIPLE MYELOMA: Thursday, 11 June WELCOME LETTER Dear Colleagues, Welcome to Vienna and the 20 th Congress of the European Hematology Association. We are very pleased that you have chosen to attend this prime Oncology satellite symposium, Relapsed/Refractory Multiple Myeloma: Embracing the Person in Personalized Care. With this educational activity, we hope to provide you with the most up-to-date and relevant information about treatment advances in multiple myeloma. We hope you will find our symposium informative and engaging. We appreciate your attendance and welcome your active participation. Antonio Palumbo, MD University of Torino Torino, Italy Room C1 Reed Messe Vienna AGENDA Welcome and introduction Antonio Palumbo, MD Keynote lecture Tailoring therapy in relapsed/refractory multiple myeloma (MM): Balancing the science with the individual Antonio Palumbo, MD Moving forward with immunomodulatory agents in MM Meletios Dimopoulos, MD Patient experience with immunomodulatory agents Yelak Biru Q & A Progress in proteasome inhibition: Today and tomorrow Jesús San Miguel, MD, PhD Patient experience with proteasome inhibitors Yelak Biru Q & A What lies ahead? Future therapeutic strategies Paul Richardson, MD Patient experience addressing what lies ahead Yelak Biru Q & A Taking next steps: A panel discussion Key points and adjourn CHAIR Antonio Palumbo, MD University of Torino Torino, Italy FACULTY Meletios Dimopoulos, MD University of Athens Athens, Greece Paul Richardson, MD Dana-Farber Cancer Institute Boston, Massachusetts, United States Jesús San Miguel, MD, PhD Universidad de Navarra Navarra, Spain PATIENT WITH MM Mr. Yelak Biru Dallas, Texas, United States 2 3
3 ACTIVITY OVERVIEW TARGET AUDIENCE This educational activity is designed for hematologists, oncologists, and other healthcare professionals interested and/or involved in the treatment of patients with relapsed/refractory MM. LEARNING OBJECTIVES After successful completion of this educational activity, participants should be able to: Discuss patient perspectives on evolving therapeutic strategies for relapsed/refractory MM, including the impact of mode of drug administration and treatment-related adverse events on quality of life Employ best practices in the treatment of patients with relapsed/refractory MM, including optimal use of available agents, such as immunomodulatory drugs and proteasome inhibitors Evaluate recent clinical trial data and ongoing studies focused on the efficacy and safety of novel therapies for the treatment of relapsed/refractory MM Describe how emerging therapeutic options may fit into the current treatment landscape for relapsed/refractory MM Identify strategies to balance quality of life and efficacy when making treatment decisions for patients with relapsed/refractory MM CONTINUING EDUCATION prime Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME ) to provide continuing medical education for physicians. prime Oncology designates this live activity for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. PROVIDER This activity is provided by prime Oncology. SUPPORT This educational activity is supported by grants from Bristol-Myers Squibb; Celgene; Novartis Oncology; and Onyx Pharmaceuticals, an Amgen subsidiary. ACTIVITY OVERVIEW DISCLOSURE Disclosure of Relevant Financial Relationships prime Oncology assesses relevant financial relationships with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. Any potential conflicts of interest that are identified are thoroughly vetted by prime Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prime Oncology is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity. The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interest related to the content of this activity: Mr Biru has disclosed that he has no relevant financial relationships to disclose. He has agreed to disclose any unlabeled/unapproved uses of drugs or products referenced in his presentation. Dr Dimopoulos has disclosed that he has received honoraria/consulting fees from Celgene, Janssen, Novartis, and Onyx. He has agreed to disclose any unlabeled/unapproved uses of drugs or products referenced in his presentation. Dr Palumbo has disclosed that he has performed as a consultant or advisor for Amgen, Bristol- Myers Squibb, Genmab A/S, Celgene, Janssen-Cilag, Millennium Pharmaceuticals, Inc., and Onyx Pharmaceuticals. Furthermore, he disclosed receipt of honoraria from Amgen, Bristol- Myers Squibb, Genmab A/S, Celgene, Janssen-Cilag, Millennium Pharmaceuticals, Novartis, Onyx Pharmaceuticals, and Sanofi Aventis. He has agreed to disclose any unlabeled/ unapproved uses of drugs or products referenced in his presentation. Dr Richardson has disclosed that he was a member of the Advisory Committees of Bristol Myers Squibb, Celgene, Genmab, Johnson & Johnson, Millennium, Novartis, and Onyx. He has agreed to disclose any unlabeled/unapproved uses of drugs or products referenced in his presentation. Dr San Miguel has disclosed that he has been on the advisory board for Bristol-Myers Squibb, Celgene, Janssen, Millennium, MSD, Novartis, and Onyx. He has agreed to disclose any unlabeled/unapproved uses of drugs or products referenced in his presentation. The employees of prime Oncology have disclosed: Janice Galleshaw, MD (medical director content reviewer/planner) no relevant financial relationships Sanneke Koekkoek, RN (clinical content reviewer/planner) no relevant financial relationships Christi Gray (editorial content reviewer) no relevant financial relationships 4 5
4 ACTIVITY OVERVIEW CHAIR BIOGRAPHY Disclosure Regarding Unlabeled Use This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients conditions and possible contraindications or dangers in use, review of any applicable manufacturer s product information, and comparison with recommendations of other authorities. Antonio Palumbo, MD Antonio Palumbo, MD, received his medical degree, served his residency in internal medicine, and held a fellowship in hematology/oncology at the University of Torino in Italy. Before his current position as chief of the Myeloma Unit of the Department of Oncology, Section of Hematology, University of Torino, he was a research associate at the Wistar Institute, University of Pennsylvania in the United States. Dr Palumbo specializes in malignant hematology and medical oncology and has clinical and research interest in plasma cell dyscrasia. In addition to membership in numerous professional organizations, he has authored more than 100 publications in peer-reviewed journals, as well numerous abstracts and several textbooks chapters. His current research focuses on the pathogenesis and treatment of multiple myeloma. 6 7
5 FACULTY BIOGRAPHY FACULTY BIOGRAPHY Mr. Yelak Biru Diagnosed at a young age of 25 with stage III myeloma, Yelak Biru is a patient turned myeloma research advocate. Working with a team of medical practitioners and educating himself through active support group leadership, online information, advocacy sites, social media, and the IMF, Yelak has been able to successfully integrate myeloma to his life for almost two decades. From the time he was told he has, give or take, three years to live in 1996, Yelak has learned to balance life based on the realization that life is both brittle and finite, and he has come to realize the uncertainty of myeloma treatment and its outcomes keeping hope based on the reality of continuing time and the possibilities of tomorrow. Sharing that hope is his personal motivation and the motto of the North Texas Myeloma Support Group, one of the oldest myeloma support groups in North America of which he leads. Yelak has attended a half dozen American Hematology Association conferences, myeloma satellite symposiums, International Myeloma Working Group breakfasts, debates, and regional and community myeloma workshops, where he has been able to hear from leading myeloma researchers and practitioners. Yelak believes through research advocacy patients will be able to better balance quality of life with treatment outcomes while helping to accelerate both translational and basic myeloma research. Mr Biru has been treated with the old dog treatment regimen of VAD (vincristinedoxorubicin-dexamethasone) as well as with novel immunomodulatory drugs and proteasome inhibitors both as induction and maintenance, and he has so far avoided stem cell transplant. Meletios Dimopoulos, MD Meletios Dimopoulos, MD, is professor and chairman of the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens School of Medicine, Athens, Greece. He was elected vice dean of the medical school from 2007 to 2011, and he became dean in In February 2015, he was elected Rector of the National and Kapodistrian University of Athens for a 4 year term. He obtained his medical degree from the University of Athens in 1985, completed a residency in internal medicine at the Royal Victoria Hospital, McGill University in Montreal, Canada, and completed a fellowship in hematology/oncology at the University of Texas M.D. Anderson Cancer Center in Houston, Texas, United States. Dr Dimopoulos is a member of numerous scientific societies, and has authored more than 700 publications in peer-reviewed journals, as well as numerous abstracts and several textbook chapters primarily focusing on plasma cell dyscrasias and genitourinary and gynecologic cancers. He has more than 24,000 citations and his H-index is 75. He is a journal reviewer for several journals, including New England Journal of Medicine, Blood, Journal of Clinical Oncology, Haematologica, Leukemia, Cancer, European Journal of Haematology, Leukemia, and Lymphoma. He was associate editor of the European Journal of Internal Medicine ( ), is an associate editor of Current Hematologic Malignancy Reports, and was an editorial board member of the Journal of Clinical Oncology ( ). He is currently on the editorial board of Haematologica, Leukemia and Lymphoma, Clinical Lymphoma and Myeloma, and Expert Review of Hematology. 8 9
6 FACULTY BIOGRAPHY FACULTY BIOGRAPHY Paul Richardson, MD Paul Richardson, MD, earned his medical degree at the Medical College of St Bartholomew s Hospital, University of London, in the United Kingdom. His postdoctoral training included an internship in the Departments of Medicine and Surgery at St Bartholomew s Hospital; residency in the Department of Medicine at Newcastle University School of Medicine, Newcastle General and Freeman Hospitals in Newcastle-upon-Tyne; chief residency in medical oncology at the Royal Marsden Hospital in London and Surrey; and additional residency training at the Beth Israel Hospital in Boston, Massachusetts, United States. He completed fellowships in hematology/oncology and medical oncology at Tufts University School of Medicine, Baystate Medical Center, and Harvard Medical School, Dana- Farber Cancer Institute, all in Massachusetts. Board certified in internal medicine, medical oncology, and hematology, Dr Richardson holds leadership positions in several professional bodies and serves on the editorial board for a number of journals, including the British Journal of Haematology, The Oncologist, and Clinical Cancer Research. He is past-chair of the Multiple Myeloma Research Consortium, Clinical Trials Core, and served on the American Society of Clinical Oncology ACRA Hematologic Malignancies Subcommittee. He is currently chairman of the Myeloma Committee for the Alliance (the former CALGB). His honors include several Massachusetts General Hospital, Brigham and Women s Hospital, and Dana-Farber Partners in Excellence Awards; the Brigham and Women s Hospital Teaching Scholars Award; the Dana-Farber Cancer Institute s George Canellos Award for Excellence in Clinical Research and Patient Care; the Tisch Family Outstanding Achievement Award, and the Warren Alpert Foundation Prize. Dr Richardson has published more than 280 original articles, and more than 220 reviews, chapters, and editorials in top peer-reviewed journals including the New England Journal of Medicine, Blood, Journal of Clinical Oncology, Lancet Oncology, Leukemia, Clinical Cancer Research, Hematologica, and British Journal of Haematology. Jesús San Miguel, MD, PhD Jesús San-Miguel, MD, PhD, is a professor of medicine-hematology and director of clinical and translational medicine at the University of Navarra in Spain. He served as director of the Hematology Department of the University Hospital of Salamanca in Spain, for over 22 years ( ). Dr San-Miguel has published over 700 original papers in international journals with a median impact factor of 7.6 in the last five years. His areas of interest include multiple myeloma (MM), the biology of malignant cells and their prognostic implications, and minimal residual disease. He has made important contributions to myeloma cell biology in areas such as immunephenotyping, risk of progression from monoclonal gammopathy of undetermined significance or smouldering MM into active MM, and minimal residual disease, as well as, making important contributions in the area of therapeutics, including studies for new antimyeloma drugs at the preclinical and clinical levels, including proteasome inhibitors, immunemodulatory drugs, and histone deacetylases. He is a member of the Advisory Board of the International Myeloma Foundation and the Multiple Myeloma Research Foundation. He has served as board councillor for the European Association, chairman of the Scientific Committee for the IXth Congress (2004), and president of the 15th European Hematology Association (EHA) Congress. He is associate editor for Blood. He has received numerous awards, including the Waldenstöm Award, Kyle Lifetime Achievement Award, Jose Carreras EHA Award, Ham-Wasserman Lecture Award, Rey Jaime I Award in Clinical Medicine, and the Spanish Prizes in both oncology and translational research. Dr Richardson is a highly sought invited lecturer both nationally and internationally. Currently, he is leading multiple efforts studying the use of combination therapies in relapsed and refractory myeloma, an area of primary interest to him. He is also serving as a principal investigator and study chairman for several large multicenter clinical trials relating to other areas of myeloma treatment, including the use of combination therapies as initial treatment and timing of stem cell transplant in earlier disease designed to target resistance and reduce toxicity
7 Notes Notes IDEAS, FACTS, OR CONCEPTS TO REMEMBER QUESTIONS I CAN USE THIS IN MY PRACTICE 12 13
8 Notes Notes IDEAS, FACTS, OR CONCEPTS TO REMEMBER QUESTIONS I CAN USE THIS IN MY PRACTICE 14 15
9 Webcast and downloadable slide will be availabe in July at
10 EU Office prime Oncology Schenkkade 50, Suite AR The Hague the Netherlands tel US Office prime Oncology Two Concourse Pkwy, Suite 260 Atlanta, Georgia United States tel About prime Oncology prime Oncology is a global professional Independent Medical Education organization specializing in educational activities for physicians who treat patients with cancer. With the ultimate goal of improving patient outcomes, prime Oncology provides evidence-based, state-of-the-art educational activities that assist oncology clinicians in making up-to-date and appropriate treatment decisions prime Oncology PI5LMS033
Personalized, Targeted Treatment Options Offer Hope of Multiple Myeloma as a Chronic Disease
/publications/targeted-therapy-news/2012/november-2012/personalized-targeted-treatment-options- Offer-Hope-of-Multiple-Myeloma-as-a-Chronic-Disease Personalized, Targeted Treatment Options Offer Hope of
More informationCaring for Oncology Patients:
: Tips and Tools for Managing Targeted Therapy Side Effects ehandbook These independent CME/CE activities are supported by educational grants from Genentech Bio Side Effects ehandbook Table of Contents
More informationINTERPRETING CLINICAL DATA: Highlights From ASCO 2016
INTERPRETING CLINICAL DATA: Highlights From ASCO 2016 SATURDAY, JUNE 25, 2016 Detroit Marriott - Troy, MI AGENDA Time Topic Speaker 7:30 am Registration and Continental Breakfast 8:00 am Opening Remarks/Welcome
More informationClinical and Health Policy Innovation Seminar for Hematologists. An Executive seminar for Senior Clinicians
Clinical and Health Policy Innovation Seminar for Hematologists. An Executive seminar for Senior Clinicians From May 6 th to 10 th, 2013 INTRODUCTION The Universitat Internacional de Catalunya (UIC) and
More informationMeaningful Use of EHR: First Steps To Improved Patient Outcomes
Meaningful Use of EHR: First Steps To Improved Patient Outcomes Jointly sponsored by Postgraduate Institute for Medicine. Learn How to Achieve Meaningful Use In Your Practice With New Online Education
More informationPhysician Education Day
NON-PROFIT ORG US POSTAGE PAID Permit #72 Holliston, MA 5. Discuss potential treatment options for type 2 diabetes. We are all so busy in our hectic schedules that unless we engage in a specific conversation
More informationResumen Curricular de los Profesores. Jesse Boehm
Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub
More informationBONE MARROW FAILURE DISEASE SYMPOSIUM SATURDAY SEPTEMBER 27, 2014 AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT
SATURDAY SEPTEMBER 27, 2014 THE HOTEL HERSHEY 100 Hotel Road, Hershey, PA 17033 BONE MARROW FAILURE DISEASE SYMPOSIUM AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT A CONTINUING EDUCATION SERVICE OF
More informationYear Founded Began serving Memphis and North Mississippi patients in 1997
2015 Press Kit www.thejonesclinic.com THE JONES CLINIC FACT SHEET In an ever-changing healthcare environment, where specialized medical practices are aligning with large corporate hospitals by the dozen,
More informationELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
More informationAgenda. 8:30 9:00 AM Breakfast. 9:00 9:15 AM Welcome and Introduction. 9:15 9:30 AM Workshop 1. 9:30 9:45 AM RA Overview. 9:45 10:00 AM Break
Agenda 8:30 9:00 AM Breakfast 9:00 9:15 AM Welcome and Introduction 9:15 9:30 AM Workshop 1 9:30 9:45 AM RA Overview 9:45 10:00 AM Break 10:00 10:30 AM Current Management of RA 10:30 11:00 AM Case Study
More informationA Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
More informationASH Review. Wednesday, January 21, 2015. Renaissance Cleveland Hotel. 24 Public Square Cleveland, Ohio. 15th Annual
15th Annual ASH Review Wednesday, January 21, 2015 24 Public Square Cleveland, Ohio About the Course This course will provide hematologists, medical oncologists, radiation oncologists and nurses with current
More informationBrooklyn Stroke Symposium 2015
Brooklyn Stroke Symposium 2015 May 28, 2015 Brooklyn Public Library Grand Army Plaza Sponsored by Keynote Presentations Sleep Apnea and Stroke: More than a Snore Devin L. Brown, M.D., M.S. Professor of
More informationHow To Choose A Pediatric Oncologist
Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the
More informationPediatric Asthma & Allergy Updates
Pediatric Asthma & Allergy Updates PEDIATRIC ASTHMA & ALLERGY UPDATES FOR for PRIMARY PrimAry CARE CAre PROVIDERS Providers March March 22, 28, 2013 2014 Boston, Children s MA Hospital Boston, MA Course
More informationOKLAHOMA PROSTATE CANCER SYMPOSIUM
OKLAHOMA PROSTATE CANCER Saturday, September 26, 2015 Stephenson Cancer Center, OU Health Sciences Center Oklahoma City, OK Earn up to 5.5 AMA PRA Category 1 Credits TM Register online: cme.ouhsc.edu Michael
More informationWaiver to Allow Participation in a Food and Drug Administration Advisory Committee
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring MD 20993 Waiver to Allow Participation in a Food and Drug Administration Advisory Committee DATE:
More informationINTRODUCTION TO THE PRACTICE OF AMERICAN MEDICINE. Introduction to the Practice of American Medicine
INTRODUCTION TO THE PRACTICE OF AMERICAN MEDICINE Introduction to the Practice of American Medicine IPAM A two-day workshop designed to prepare candidates to apply for medical residency training in the
More informationMultiple Sclerosis in Practice. An Expert Commentary With Jeffrey Cohen, MD, PhD A Clinical Context Report
Multiple Sclerosis in Practice An Expert Commentary With Jeffrey Cohen, MD, PhD A Clinical Context Report Clinical Context: Multiple Sclerosis in Practice Expert Commentary Jointly Sponsored by: and Clinical
More informationHouston Cancer Institute
Houston Cancer Institute A personal path to healing Memorial-West Houston Katy Northwest Houston Southeast Houston Sugar Land Convenience for Patients State of the Art Therapies and Diagnosis Real Support
More informationDERMATOLOGY FOR PRIMARY CARE
DERMATOLOGY FOR PRIMARY CARE Scottsdale, Arizona The Phoenician February 13 15, 2015 Participating Faculty Jennifer Krejci-Manwaring, MD Assistant Professor, University of Texas Health Science Center Staff
More informationTo register to attend this event, please visit www.aahivm.org/events/exec/events.
HIV Care Under the Affordable Care Act: Addressing the Needs of HIV Providers & Health Professionals In Arizona A policy training event with CME/CE credit available for MDs, DOs, PAs, NPs, RNs, Pharm Ds,
More informationCURRICULUM VITAE. (b) (6) University of Oklahoma Health Sciences Center. Director of Clinical Research Unit Department of Dermaology
CURRICULUM VITAE NAME: ADDRESS: PLACE OF BIRTH: PRESENT TITLE: PREVIOUS TITLES Lynn Annette Drake, M.D. Harvard Medical School Massachusetts General Hospital 40 Blossom Street - BAR 604 Boston, MA 02114-2696
More informationPublished by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen Maxwell, GLM Design
Copyright 2007 Scott M. Fishman, MD CME Activity Copyright 2009 The University of Wisconsin Board of Regents Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen
More informationAdvanced Management Issues in HIV Medicine
Is a Cure Possible for HIV? Department of Infectious Disease and R.J. Fasenmyer Center for Clinical Immunology 6th Annual Advanced Management Issues in HIV Medicine May 30 31, 2013 InterContinental Hotel
More informationMultiple Myeloma (Event Driven)
Brochure More information from http://www.researchandmarkets.com/reports/2234830/ Multiple Myeloma (Event Driven) Description: The 2010 multiple myeloma (myeloma) market garnered impressive sales despite
More informationSCOPE of Pain: Safe and Competent Opioid Prescribing Education
SCOPE of Pain: Safe and Competent Opioid Prescribing Education Disclosure of Support Our program is funded by an independent educational grant awarded by the manufacturers of extended-release (ER) and
More informationDaiichi Sankyo to Acquire Ambit Biosciences
For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please
More informationDuke Regional Diabetes Symposium 2012
Duke Regional Diabetes Symposium 2012 July 13, 2012 8:30 AM 4:30 PM North Carolina Research Campus David H. Murdock Core Laboratory Building First Floor Event Room 150 Research Campus Drive Kannapolis,
More informationGIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology
More informationChoosing a Blood Cancer Specialist or Treatment Center
Choosing a Blood Cancer Specialist or Treatment Center No. 6 in a series providing the latest information for patients, caregivers and healthcare professionals www.lls.org Information Specialist: 800.955.4572
More informationThe professional development of physicians is a lifelong. Continuing Medical Education: A New Vision of the Professional Development of Physicians
A R T I C L E Continuing Medical Education: A New Vision of the Professional Development of Physicians Nancy L. Bennett, PhD, Dave A. Davis, MD, William E. Easterling, Jr., MD, Paul Friedmann, MD, Joseph
More informationResearch Associate BLOOD AND MARROW TRANSPLANT FACULTY POSITIONS HEMATOLOGY/ONCOLOGY FACULTY POSITIONS IN PRECISION CANCER MEDICINE
HEMATOLOGY/ONCOLOGY FACULTY POSITIONS IN PRECISION CANCER MEDICINE The Division of Hematology/Oncology, Department of Internal Medicine, and the University of Michigan Comprehensive Cancer Center (UMCCC)
More informationAdvances in B Cell Biology:
R.J. Fasenmyer Center for Clinical Immunology and Phoenix Rheumatology Association Advances in B Cell Biology: RA, SLE, and Vasculitis Saturday, February 18, 2012 Gainey Ranch Golf Club Scottsdale, AZ
More informationSp12 SYLLABUS: Going Paperless
Sp12 SYLLABUS: Going Paperless Introduction The Going Paperless course is an introduction to the process of using an electronic medical record (EMR) in a radiation oncology department. By the end of this
More informationCommunication in Serious Illness
Communication in Serious Illness June 4 6 2015 Boston, MA Earn up to: 17.75 AMA PRA Category 1 Credits 12.00 credits of End-of-Life Care Studies 12.00 credits Risk Management Study Register at SeriousIllness.HMSCME.com
More informationGRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native
More informationACROSS THE CONTINUUM: Optimizing Strategies for Acute to Chronic Pain Management HEALTH-SYSTEM PHARMACIST PERSPECTIVES AGENDA
Optimizing Strategies for Acute to Chronic Pain Management AGENDA 11:30 11:45 AM Conference Goals/Pre-Test J. Richard Brown, PharmD, FASHP 11:45 12:00 PM The Pain Continuum: From Acute Treatment to Chronic
More informationOctober 6, 2012 Golden Tulip Hotel, Beirut, Lebanon
The Salim El-Hoss Bioethics and Professionalism Program at the, Faculty of Medicine In collaboration with the Lebanese Order of Physicians And In joint sponsorship with Cleveland Clinic announces its 5
More information2015 ANNUAL CONFERENCE
2015 ANNUAL CONFERENCE Professional Education Services Group Continuing Education Activity Development Guidance Document The information contained in this document has been prepared for the exclusive for
More informationCARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary
More informationInnovations in Pediatric Hematology/Oncology: Today s Practice, Tomorrow s Possibilities
Innovations in Pediatric Hematology/Oncology: Today s Practice, Tomorrow s Possibilities Friday, May 29, and Saturday, May 30, 2015 Emory Conference Center Hotel 1615 Clifton Road NE Atlanta, GA 30329
More informationAdvancing Quality Care in the Pediatric Emergency Department
Cohen Children s Medical Center Presents: The 5 th Annual Pediatric Emergency Medicine Symposium Advancing Quality Care in the Pediatric Emergency Department 7:30 am 1:00 pm Einhorn Auditorium 100 East
More informationHeart Failure: From Prevention to Intervention
Sharp HealthCare Presents Heart Failure: From Prevention to Intervention Saturday, May 16, 2015 DoubleTree by Hilton Hotel San Diego - Mission Valley San Diego, Calif. As medical professionals, we know
More informationAdvances in Stroke Care
Advances in Stroke Care 2015 Friday October 2 7 a.m. to 4:30 p.m. Hyatt Regency New Brunswick Two Albany Street New Brunswick, NJ 08901 Jointly sponsored by the Comprehensive Stroke Center Robert Wood
More informationThoracic Oncology for the Non-Oncologist
Mayo Clinic Cancer Center Lung Cancer Symposium Thoracic Oncology for the Non-Oncologist $75 DISCOUNT for online registration! Go to www.mayo.edu/cme (offer expires October 12, 2011) Saturday, November
More informationStakeholder Insight: Acute Leukemias - Reaching the Limits of Cytotoxic Chemotherapy
Brochure More information from http://www.researchandmarkets.com/reports/1088137/ Stakeholder Insight: Acute Leukemias - Reaching the Limits of Cytotoxic Chemotherapy Description: The drug therapy of acute
More informationUpdate on Indications, Techniques and Controversies for Lead Extraction
Update on Indications, Techniques and Controversies for Lead Extraction W Boston 100 Stuart Street, Boston, MA Course Directors Avi Fischer, MD Laurence M. Epstein, MD Brigham and Women s Hospital Sponsored
More informationEarning and redeeming CME/CE/CPD credit
Earning and redeeming CME/CE/CPD credit A step-by-step guide for clinicians accessing UpToDate through an EHR, clinician portal or other secure clinical system GET STARTED EARNING CME/CE/CPD CREDIT REGISTER
More informationSPEAKER BIOGRAPHICAL INFORMATION
SPEAKER BIOGRAPHICAL INFORMATION Madeleine R. Valera MD, MScIH (Heidelberg) Dr. Valera is a senior health care service professional with over 20 years of professional expertise in Health Financing and
More informationIn ELOQUENT-2, Empliciti was evaluated in patients who had received one to three prior
- First and only immunostimulatory antibody approved in the European Union for multiple myeloma - Accelerated assessment and approval based on long-term data from ELOQUENT-2, which evaluated Empliciti
More information30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
More informationBest of San Antonio Breast Cancer Symposium
Best of San Antonio Breast Cancer Symposium 11:45 am - 5:00 pm 5800 Rockside Woods Blvd. About the Course The San Antonio Breast Cancer Symposium is an international meeting of laboratory and clinical
More informationThe Blood Cancer Twice As Likely To Affect African Americans: Multiple Myeloma
The Blood Cancer Twice As Likely To Affect African Americans: Multiple Myeloma 11 th Annual National Leadership Summit on Health Disparities Innovation Towards Reducing Disparities Congressional Black
More information23 rd Annual Conference on Cardiovascular Nursing
23 rd Annual Conference on Cardiovascular Nursing Thursday, April 11, 2013 7:00 am - 3:45 pm Boston Marriott Newton Newton, MA Keynote Speaker Marvin A. Konstam, MD Chief Physician Executive, The CardioVascular
More informationAccreditation Statement...2. CME Content Validation...2. Commercial Support and Disclosure...3. Credit Certificates for CME...6
Including Information for Provider Implementation (UMA) policies supplement the Essential Areas and Elements and result from actions taken by UMA s Accreditation Committee. These policies were developed
More informationCLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD
CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD Gwen L. Nichols, M.D., is currently the Oncology Site Head of the Roche Translational Clinical Research Center at Hoffman- LaRoche. In this
More informationANNUAL ANNUAL. Friday, June 17, 2011 The Desmond Hotel and Conference Center. 660 Albany-Shaker Road Albany, New York
29 ANNUAL ANNUAL th Friday, June 17, 2011 The Desmond Hotel and Conference Center 660 Albany-Shaker Road Albany, New York Sponsored by Albany Medical College s Office of Continuing Medical Education in
More informationCoronary CTA in the Emergency Department A Hands-on Workshop
Coronary CTA in the Emergency Department A Hands-on Workshop November 7-8, 2009 Eden Roc Hotel Miami Beach, Florida Symposium Director Coronary CTA in the Emergency Department: A Hands-on Workshop Target
More informationLung Cancer in 2015: A Multidisciplinary Update
Lung Cancer in 2015: A Multidisciplinary Update Invited Guest Faculty: Toronto General Hospital Toronto, Canada Saturday April 18, 2015 7:00 am-4:30 pm Westin Pasadena 191 N. Los Robles Avenue Pasadena,
More informationPertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer
Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians and basic scientists
More informationUniversity of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents
University of Central Florida College of Medicine Industry Relations Policy and Guidelines 1. Introduction and Scope of Policy 2. Statement of Policy Table of Contents 3. Gifts and Individual Financial
More informationThe Royal Australasian College of Physicians. Curricula Renewal Curriculum Advisory Group members. Page 1. RACP Curricula Renewal
The Royal Australasian College of Physicians Curricula Renewal Curriculum Advisory Group members Page 1 A/Prof Martin Veysey FRACP Chair, Curriculum Advisory Group Martin is a Gastroenterologist and an
More informationThe University of Toledo College of Medicine and Life Sciences Faculty Tracks for Academic Rank and Criteria for Promotion
The University of Toledo College of Medicine and Life Sciences Faculty Tracks for Academic Rank and Criteria for Promotion Faculty Tracks for Academic Rank. There are six tracks for full-time and part-time
More informationINTERNAL CARE: March 7 9, 2014. Speaker 1 Affiliation. Speaker 2 Affiliation. Speaker 3 Affiliation
INTERNAL MEDICINE FOR PRIMARY CARE: CARDIOVASCULAR/DERMATOLOGY/ORTHOPEDICS Las Vegas, Nevada The Cosmopolitan March 7 9, 2014 Participating Faculty Speaker 1 Affiliation Speaker 2 Affiliation Speaker 3
More informationIncreasing Patient Access through Oral Parity Legislation
Increasing Patient Access through Oral Parity Legislation The Leukemia & Lymphoma Society A powerhouse among nonprofits searching for cancer cures Our Mission; Cure leukemia, lymphoma, Hodgkin s disease
More informationCurriculum Vitae. Name: Alison Richardson, Clinical Professor of Cancer Nursing & End of Life Care
Curriculum Vitae Name: Alison Richardson, Clinical Professor of Cancer Nursing & End of Life Care Born: 29 th December 1962 Work: University Hospital Southampton NHS Foundation Trust & University of Southampton
More informationBEGINNER & INTERMEDIATE
PROVIDED BY THE NYU POST-GRADUATE MEDICAL SCHOOL HOSPITAL FOR JOINT DISEASES BEGINNER & INTERMEDIATE MARCH 19-20, 2016 NEW YORK, NY Course Director Jonathan Samuels, MD Highlighted Topics: Sonoanatomy
More informationSteven E. Wolf, MD, FACS, University of Texas Southwestern
Steven E. Wolf, MD, FACS, University of Texas Southwestern Dr. Wolf is an established researcher and clinician in the field of burn/trauma care. He is currently the Chief of Burn Services and Vice Chairman
More informationContinuing Medical Education Category 1 Credit Documentation Process UnityPoint Health - Des Moines
Continuing Medical Education Category 1 Credit Documentation Process UnityPoint Health - Des Moines UnityPoint Health - Des Moines is accredited by the Iowa Medical Society (IMS) to provide continuing
More informationMeet Your Sparrow Cancer Center Team
Meet Your Sparrow Cancer Center Team Our integrated, multidisciplinary approach means every Patient is evaluated and cared for by a team managing all aspects of care from tests and treatments, to infusions,
More informationVeterans Health Administration Employee Education System. And. VACO Office of Quality and Safety, Evidenced Based Practice And
Veterans Health Administration Employee Education System And VACO Office of Quality and Safety, Evidenced Based Practice And Department of Defense TRICARE Management Activity And U.S. Army Medical Command,
More informationAddictions 2015. Treatment Comorbidities Complex Cases
Addictions 2015 Treatment Comorbidities Complex Cases May 29 30, 2015 Cambridge, MA For Physicians, Addiction Specialists, Mental Health Professionals, Nurses, Nurse Practitioners & Social Workers Strategies,
More informationShaji Kumar, M.D. Multiple Myeloma: Multiple myeloma (MM) is the second most common hematological
An update on the management of multiple myeloma and amyloidosis Shaji Kumar, M.D. Multiple Myeloma: Multiple myeloma (MM) is the second most common hematological malignancy in this country affecting nearly
More informationCARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. San Diego, California San Diego Marriott Marquis & Marina October 3 5, 2014. Participating Faculty
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE San Diego, California San Diego Marriott Marquis & Marina October 3 5, 2014 Participating Faculty Hector O. Ventura, MD, FACC Section Head, Cardiomyopathy and
More informationApplied Behavior Analysis: Not Just for Autism! Evidence-Based Solutions for Teaching Children with Special Needs
Mayo Clinic Dana Child Development and Learning Disorders Program Annual Symposium Applied Behavior Analysis: Not Just for Autism! Evidence-Based Solutions for Teaching Children with Special Needs Guest
More informationCURRICULUM VITAE. Professional Training 1981-1982 Intensive Training Program in Family Therapy, Family Institute of Cambridge, Cambridge, MA
CURRICULUM VITAE JANICE N. FURLONG, MSW, LICSW 264 Bay State Road Boston, MA 02215 617-353-3662 jfurlong@bu.edu Education 1979 M.S.W., Simmons College School of Social Work, Boston, MA Internships: 1978-1979
More information11th Annual National Summit on Health Disparities/ CBC Health Braintrust Meeting & Awards Dinner
11th Annual National Summit on Health Disparities/ CBC Health Braintrust Meeting & Awards Dinner 7:00 AM REGISTRATION & BREAKFAST Welcome Opening Session Congresswoman Donna M. Christensen, CBC Health
More information21st Annual OSF Cardiovascular Symposium
21st Annual OSF Cardiovascular Symposium new waves in cardiac electrophysiology saturday 18 october 2014 7:00 a.m. 4:00 p.m. embassy suites conference center east peoria, illinois OBJECTIVES Overall Program:
More informationMinimally Invasive Gynecologic Surgery Course and Cadaver Lab
Minimally Invasive Gynecologic Surgery Course and Cadaver Lab FEBRUARY 27-28, 2016 TAMPA, FLORIDA CAMLS (Center for Advanced Medical Learning and Simulation) Provided by: www.gynlap.com www.camls-us.org
More informationFuture strategies for myeloma: An overview of novel treatments In development
Future strategies for myeloma: An overview of novel treatments In development Dr. Matthew Streetly Guys and St. Thomas NHS Trust How far have we come? Melphalan and prednisolone VAD Autologous SCT Thalidomide
More informationEastern North Carolina Lung Cancer Symposium
Eastern North Carolina Lung Cancer Symposium Friday, October 30, 2015 The East Carolina Heart Institute 115 Heart Drive Greenville, North Carolina Jointly Provided by The Department of Internal Medicine
More informationStrategic Consulting Services
Services 1 Leadership Team Mark Levonyak President mlevonyak@davaonc.com Mobile: 214.460.5051 Martin W. Lee, MD EVP, Clinical Trial Services mlee@davaonc.com Mobile: 952.373.1405 John Eckardt, MD Chief
More informationREFERENCE CODE GDHCER083-15 PUBLICAT ION DATE JULY 2015 MULTIPLE MYELOMA EPIDEMIOLOGY FORECAST TO 2023
REFERENCE CODE GDHCER083-15 PUBLICAT ION DATE JULY 2015 MULTIPLE MYELOMA Executive Summary Multiple myeloma (MM) (International Statistical Classification of Diseases and Related Health Problems, 10th
More informationENVISIONING THE FUTURE OF DERMATOLOGY THROUGH THE LENS OF MEDICAL INFORMATICS
Is pleased to announce: ENVISIONING THE FUTURE OF DERMATOLOGY THROUGH THE LENS OF MEDICAL INFORMATICS CONFERENCE LOCATION MEMORIAL SLOAN KETTERING CANCER CENTER ROCKEFELLER RESEARCH LABORATORIES BOARD
More informationA Biopharma/Foundation Partnering Model The Leukemia & Lymphoma Society Targets, Leads & Candidates Program
A Biopharma/Foundation Partnering Model The Leukemia & Lymphoma Society Targets, Leads & Candidates Program Thomas O. Daniel, MD, Celgene President Research and Early Development Louis J. DeGennaro, PhD,
More informationMomentum in Multiple Myeloma Treatment
WHITE PAPER Momentum in Multiple Myeloma Treatment Dr. Harish P. Dave, MD, MBA Dr. Ben Manderman, MD Quintiles examines promising new approaches to more effective multiple myeloma treatments. HIGH RESPONSE
More informationThis article is a CME/CE certified activity. To earn credit for this activity visit: http://www.medscape.org/viewarticle/750546
1 of 6 10/10/2011 7:17 PM This article is a CME/CE certified activity. To earn credit for this activity visit: http://www.medscape.org/viewarticle/750546 CME/CE Information CME/CE Released: 09/28/2011;
More informationFRIDAY, FEBRUARY 26, 2016 7:15 A.M. TO 3:15 P.M.
CEDARS-SINAI HYPERTENSION CENTER 2016 Clinical Highlights Symposium FRIDAY, FEBRUARY 26, 2016 7:15 A.M. TO 3:15 P.M. CONFERENCE LOCATION Harvey Morse Conference Center 8701 Gracie Allen Drive Plaza Level,
More informationState of the Art Advanced Heart Failure and Arrhythmia Management: Integrating Devices and Pharmacotherapies
The Division of Cardiology, Department of Medicine of the University of California, San Francisco School of Medicine presents State of the Art Advanced Heart Failure and Arrhythmia Management: Integrating
More informationA leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
More informationCARMEN A. PULIAFITO, M.D., M.B.A. DEAN, KECK SCHOOL OF MEDICINE OF THE UNIVERSITY OF SOUTHERN CALIFORNIA
CARMEN A. PULIAFITO, M.D., M.B.A. DEAN, KECK SCHOOL OF MEDICINE OF THE UNIVERSITY OF SOUTHERN CALIFORNIA Dr. Carmen A. Puliafito was recently reappointed to a second term as Dean of the Keck School of
More informationOPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, 33316 AGENDA
OPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, 33316 Friday, June 26 AGENDA 10:00 am - 10:45 am Registration; Breakfast
More information7th annual ConFerenCe location
Sponsors 7th Annual WOMEN and Ischemic Heart Disease Symposium Friday, April 19, 2013 Offered in cooperation with the California Chapter of the American College of Cardiology and WomenHeart: The National
More information21st Annual Cancer Symposium. Thursday, October 29, 2015
21st Annual Cancer Symposium CANCER SURVIVORSHIP Thursday, October 29, 2015 A continuing education service of and Penn State Hershey Cancer Institute Edward P. Junker III Auditorium Penn State Milton S.
More informationTarget Audience VHA/DoD physicians, nurses, pharmacists, and dieticians involved in the care of patients with chronic kidney disease.
here Veterans Health Administration Employee Education System VACO Office of Quality and Safety, Evidenced Based Practice Department of Defense TRICARE Management Activity U.S. Army Medical Command, Evidence-Based
More informationKEY ISSUES IN INTERNAL MEDICINE FOR: ENDOCRINOLOGY/GASTROENTEROLOGY/OBESITY/PSYCHIATRY
KEY ISSUES IN INTERNAL MEDICINE FOR: ENDOCRINOLOGY/GASTROENTEROLOGY/OBESITY/PSYCHIATRY Maui, Hawaii The Ritz-Carlton, Kapalua January 18 22, 2015 Participating Faculty Robert S. Brown, Jr, MD, MPH Frank
More informationTalking With Your Doctor About Multiple Myeloma: A guide to making the most of your healthcare visits
There s a lot to think about and many important decisions to make when you or someone you care for has multiple myeloma. It s important to have an ongoing conversation with your healthcare team throughout
More informationSUSAN L. SWANLUND. Texas Woman s University 5/88 College of Nursing, Dallas, Texas Critical Care/Medical-Surgical Nursing, Educator Role
SUSAN L. SWANLUND EDUCATION Ph.D. Saint Louis University 9/98 School of Nursing, Saint Louis, Missouri Concentration: Physiology and Pharmacology of Aging, Older Adults and Cardiovascular Drug Therapy
More information